Chantix Pulled Nationwide After Detection of Potentially Carcinogenic Contaminant

What’s Behind the Recall?

Nitrosamines have been found in various pharmaceutical products over recent years and are classified as probable human carcinogens. While the levels detected in Chantix may not pose an immediate danger, the FDA is taking precautionary action to prevent possible long-term health risks associated with continuous use.

What Should Patients Do?

If you are currently taking Chantix, the FDA advises you to stop using the medication and consult your healthcare provider promptly. Doctors can recommend safer alternatives or replacement therapies to support smoking cessation without added risk.